Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,086.00
Bid: 12,086.00
Ask: 12,088.00
Change: -70.00 (-0.58%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,098.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Work-from-home guidance and face masks can be back in winter in UK

Mon, 13th Sep 2021 11:19

(Alliance News) - Guidance to work from home and the mandatory use of face masks are likely to be retained as options in the Covid winter plan due to be set out by UK Prime Minister Boris Johnson.

The prime minister will tell the nation on Tuesday how the country can learn to live with the virus, underlining how vaccinations will be a central part of the response to coronavirus in the coming months.

Covid laws that are no longer required will be ditched and plans for vaccine passports for nightclubs and other large crowd venues have been shelved.

The travel traffic lights system is also expected to be scrapped and PCR tests will no longer be required for fully vaccinated travellers.

Speaking on Monday, Work & Pensions Secretary Therese Coffey said some regulations may still be needed as the NHS prepares to battle both Covid and seasonal flu in the winter months.

Asked about maintaining the work-from-home advice, she told BBC Breakfast of the need to keep some rules on the table, adding: "Whether that's with what you just mentioned or making sure statutory sick pay can be paid from day one rather than day four, as tends to happen in more regular times.

"These are the sensible measures I think that we're going to keep."

On the issue of masks, she added: "The prime minister will be setting out the Covid winter plan tomorrow. I think my approach, and I see that with a lot of employers' organisations, is about having a situation-specific approach."

It comes after Health Secretary Sajid Javid said on Sunday that vaccine passports were a "huge intrusion into people's lives" and there were no current plans to go ahead with them.

He said: "You have got to be really, really certain that's what you want to do. We have looked at it and whilst we will keep it in reserve I am pleased to say that we will not be going ahead."

However, Coffey said the introduction of vaccine passports had not been "ruled out forever".

She said: "As Sajid Javid set out yesterday, although the formal decision is still to be made, but having reflected and looked at the details of the proposal that it's not deemed necessary at this moment in time.

"But they haven't been ruled out forever. It's reflecting the fact that a lot of young people have come forward and got their vaccinations over the summer."

The government has yet to set out the plans for booster vaccinations, which are expected to be given to the most vulnerable people first.

A decision has also not yet been made by the UK's chief medical officers on extending the Covid vaccination programme to healthy 12 to 15-year-olds.

The Joint Committee on Vaccination & Immunisation has already said the margin of benefit is considered too small to support universal vaccination of healthy youngsters at this time.

Elsewhere, Neil Ferguson, whose modelling was instrumental to the UK going into lockdown in March 2020, has said he is in favour of a booster programme.

The scientist, from Imperial College London, and a member of the Scientific Advisory Group for Emergencies, told BBC Radio 4's Today programme on Monday that in the absence of social distancing measures, which he did agree with, "we are reliant on immunity building up in the population".

He added: "That happens two ways รขโ‚ฌโ€œ one through vaccination, and one through people getting infected and so the faster we can roll our additional vaccination, the better in terms of stopping people getting severely ill but also in reducing transmission."

He said the UK had been leading in Europe on vaccination until recently but other countries such as Spain, Portugal, France, Italy and Ireland "have got higher vaccination levels than us and that's largely because they have rolled out vaccination of 12 to 15-year-olds faster than us.

"They also vaccinated more recently, and we know now that vaccine effectiveness decays over time, we always expected that, and so they have more immunity in the population.

"They also principally used the Pfizer vaccine which against Delta is somewhat more effective than the AstraZeneca vaccine, so there are a set of countries in Europe with considerably more population immunity than us and I think if we want to stop the risk of the large autumn and winter wave we need to boost immunity in the population."

Ferguson said vaccinating teenagers with a first shot was the priority as the UK looks at dealing with any autumn and winter surges in Covid. But he said evidence from Israel suggested booster shots for a wider population were "very effective at further driving down transmission and infection".

Asked whether a further lockdown could be ruled out, he said "I hope so" but added that "you can't rule out anything completely".

The issue of vaccine passports has caused growing disquiet among Tory ranks, as well as facing opposition from opposition parties and industry figures.

The decision not to implement them means measures in England deviate from those in Scotland, where a motion on their introduction was passed in the Scottish Parliament on Thursday, while a decision is expected in Wales next week.

Stormont ministers have yet to reach an official position on using vaccine access passports within Northern Ireland.

By Jane Kirby and Sam Blewett

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.